These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9527899)

  • 21. Increase in beta-amyloid levels in cerebrospinal fluid of children with Down syndrome.
    Englund H; Annerén G; Gustafsson J; Wester U; Wiltfang J; Lannfelt L; Blennow K; Höglund K
    Dement Geriatr Cogn Disord; 2007; 24(5):369-74. PubMed ID: 17914261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins.
    Matsubara E; Sekijima Y; Tokuda T; Urakami K; Amari M; Shizuka-Ikeda M; Tomidokoro Y; Ikeda M; Kawarabayashi T; Harigaya Y; Ikeda S; Murakami T; Abe K; Otomo E; Hirai S; Frangione B; Ghiso J; Shoji M
    Neurobiol Aging; 2004 Aug; 25(7):833-41. PubMed ID: 15212837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
    Attems J; Jellinger KA; Lintner F
    Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abeta amyloid deposition in the language system and how the brain responds.
    Nelissen N; Vandenbulcke M; Fannes K; Verbruggen A; Peeters R; Dupont P; Van Laere K; Bormans G; Vandenberghe R
    Brain; 2007 Aug; 130(Pt 8):2055-69. PubMed ID: 17586869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal lobe pathology in amyotrophic lateral sclerosis. Do amyotrophic lateral sclerosis and Alzheimer's disease share a common etiological factor?
    Smitt PA; Troost D; Louwerse ES; de Jong JM; van Kessel DT; de Leeuw MA
    Clin Neuropathol; 1993; 12(2):88-91. PubMed ID: 8477553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
    Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
    Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-amyloid (beta/A4) deposition in the medial temporal lobe in Down's syndrome: effects of brain region and patient age.
    Armstrong RA; Smith CU
    Neurobiol Dis; 1994 Dec; 1(3):139-44. PubMed ID: 9173993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice.
    Hooijmans CR; Graven C; Dederen PJ; Tanila H; van Groen T; Kiliaan AJ
    Brain Res; 2007 Nov; 1181():93-103. PubMed ID: 17916337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
    Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
    Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
    Weiner HL; Lemere CA; Maron R; Spooner ET; Grenfell TJ; Mori C; Issazadeh S; Hancock WW; Selkoe DJ
    Ann Neurol; 2000 Oct; 48(4):567-79. PubMed ID: 11026440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndrome.
    Wegiel J; Kuchna I; Wisniewski T; de Leon MJ; Reisberg B; Pirttila T; Kivimaki T; Lehtimaki T
    Acta Neuropathol; 2002 Apr; 103(4):333-43. PubMed ID: 11904752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome.
    Mito T; Becker LE
    Exp Neurol; 1993 Apr; 120(2):170-6. PubMed ID: 8491278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of beta-amyloid deposition in the medial temporal lobe in sporadic Alzheimer's disease, Down's syndrome and normal elderly brains.
    Armstrong RA; Cairns NJ; Myers D; Smith CU; Lantos PL; Rossor MN
    Neurodegeneration; 1996 Mar; 5(1):35-41. PubMed ID: 8731380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A spatial pattern analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2010; 48(2):67-74. PubMed ID: 20602287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.
    Markesbery WR; Ehmann WD; Hossain TI; Alauddin M; Goodin DT
    Ann Neurol; 1981 Dec; 10(6):511-6. PubMed ID: 7325600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth and development of the brain in Down syndrome.
    Becker L; Mito T; Takashima S; Onodera K
    Prog Clin Biol Res; 1991; 373():133-52. PubMed ID: 1838182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.